Victory Medical Center Pharmacy Recalls Thymosin Beta-500 Vials
Victory Medical Center Pharmacy is recalling 15 vials of Thymosin Beta-500 due to lack of processing controls.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 2/5 (Moderate).
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as Class II due to a lack of processing controls. The source does not report any illnesses, injuries, or deaths.
Plain-English summary
Victory Medical Center Pharmacy in Austin, Texas, is recalling 15 vials of Thymosin Beta-500 (MDV) 10mg/ml. The recall is due to a lack of processing controls.
The affected product is identified by Lot 2032275 with an expiration date of 10/30/2026. The product was distributed in Colorado, Florida, and Texas.
Consumers should stop using the product and contact their healthcare provider or the pharmacy for further instructions.
The recalled product
- Product
- THYMOSIN BETA-500 (MDV) 10MG/ML **3ML**, VMC, Victory Medical Center Pharmacy, Austin, Texas
- Manufacturer
- Victory Medical Center Pharmacy
- Category
- Drug — Pharmacy Compounded
- Hazard
- Affected units
- 15
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- Lot
- expiry: Lot 2032275
- exp 10/30/2026
Distribution
Related recalls
Same manufacturer · Victory Medical Center Pharmacy
See all →- ModerateVictory Medical Center Pharmacy Recalls Thymosin Alpha-1 Vials
FDA (Drugs) · 2026-11-11
- ModerateVictory Medical Center Pharmacy Recalls Ascorbic Acid Vials Due to Processing Controls
FDA (Drugs) · 2026-11-11
- ModerateVictory Medical Center Pharmacy Recalls Tesamorelin Vials for Processing Control Issues
FDA (Drugs) · 2026-11-11
- ModerateVictory Medical Center Pharmacy Recalls Dexpantenol Due to Processing Controls
FDA (Drugs) · 2026-11-11
- ModerateVictory Medical Center Pharmacy Recalls Methylcobalamin Vials Due to Processing Controls
FDA (Drugs) · 2026-11-11
Same hazard · processing controls
See all →- ModerateVictory Medical Center Pharmacy Recalls CJC-1295/IPamorelin Due to Processing Controls
FDA (Drugs) · 2026-11-11
- ModerateVictory Medical Center Pharmacy Recalls Tirzepatide/Niacinamide Due to Processing Controls
FDA (Drugs) · 2026-11-11
Similar recalls
- ModerateVictory Medical Center Pharmacy Recalls Thymosin Alpha-1 Vials
FDA (Drugs) · 2026-11-11
- ModerateVictory Medical Center Pharmacy Recalls BPC-157/Thymosin Beta-4 Vials
FDA (Drugs) · 2026-11-11
- ModerateVictory Medical Center Pharmacy Recalls Biotin Vials for Processing Control Issues
FDA (Drugs) · 2026-11-11
- ModerateVictory Medical Center Pharmacy Recalls Tesamorelin Vials for Processing Control Issues
FDA (Drugs) · 2026-11-11
- ModerateVictory Medical Center Pharmacy Recalls BPC-157 Vials for Processing Control Issues
FDA (Drugs) · 2026-11-11
- ModerateVictory Medical Center Pharmacy Recalls Methylcobalamin Vials Due to Processing Controls
FDA (Drugs) · 2026-11-11